Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo

Background: In DR Congo, adolescent girls are disproportionately vulnerable to HIV. Nonetheless, females are often more engaged in the health-care system, including during antenatal care, when women enrolled on Option B+ for prevention of mother-to-child transmission of HIV initiate antiretroviral t...

Full description

Bibliographic Details
Main Authors: Sarina Dane, Tania Tchissambou, Désiré Dibulundu, Caitlin Madevu-Matson, Bibola Ngalamulume-Roberts, Faustin Malele Bazola, Juliana Soares Linn
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X18301608
_version_ 1831705158107529216
author Sarina Dane
Tania Tchissambou
Désiré Dibulundu
Caitlin Madevu-Matson
Bibola Ngalamulume-Roberts
Faustin Malele Bazola
Juliana Soares Linn
author_facet Sarina Dane
Tania Tchissambou
Désiré Dibulundu
Caitlin Madevu-Matson
Bibola Ngalamulume-Roberts
Faustin Malele Bazola
Juliana Soares Linn
author_sort Sarina Dane
collection DOAJ
description Background: In DR Congo, adolescent girls are disproportionately vulnerable to HIV. Nonetheless, females are often more engaged in the health-care system, including during antenatal care, when women enrolled on Option B+ for prevention of mother-to-child transmission of HIV initiate antiretroviral therapy (ART). We aimed to understand the extent of delayed ART initiation among adolescents and young adults newly enrolled in HIV care, and to assess whether there were any sex differences. Methods: Aggregate data from 365 ICAP-supported sites in Kinshasa and Haut-Katanga provinces in DR Congo from April 2016 to May 2017 were reviewed to describe delayed ART uptake among adolescents and young adults aged 15–24 years. Delayed uptake was defined as not beginning treatment within 1 month of enrolling in care among those eligible for ART. Pregnant and non-pregnant women were combined since available data did not disaggregate by pregnancy status. DR Congo began implementing “test and start” during the study period. All analyses used group-level data and were conducted using multivariable logistic regression, adjusting for setting and age group. Findings: Between April 2016 and May 2017, 861 adolescents and young adults (128 male and 733 female) enrolled in HIV care and treatment services. 21 (16%) males and 58 (8%) females had not begun treatment within 1 month of enrolling in care, despite eligibility for ART (odds ratio [OR] 2·28, 95% CI 1·33–3·92). The male predominance remained after controlling for setting (urban vs rural) and age group (15–19 years vs 20–24 years) (adjusted OR 2·03, 95% CI 1·17–3·53). Aggregate data did not allow for analysis of individual explanations, but reasons for delayed ART may include the need to stabilise patients before starting treatment and patients’ preferences. Interpretation: Despite being more vulnerable to HIV, female adolescents and young adults have faster ART initiation than males after enrolling in HIV treatment. It is likely that Option B+ expedites ART initiation for females. Going forwards, ICAP will strengthen its adolescent package of support with community-based adolescent-friendly interventions targeting males, with the goal to enrol all adolescents and young adults on ART in accordance with DRC's test and start guidelines. Funding: CDC/PEPFAR.
first_indexed 2024-12-20T16:14:01Z
format Article
id doaj.art-398508a1bd0945d68eb86437b81aed43
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-20T16:14:01Z
publishDate 2018-03-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-398508a1bd0945d68eb86437b81aed432022-12-21T19:33:52ZengElsevierThe Lancet Global Health2214-109X2018-03-016S2S3110.1016/S2214-109X(18)30160-8Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR CongoSarina Dane0Tania Tchissambou1Désiré Dibulundu2Caitlin Madevu-Matson3Bibola Ngalamulume-Roberts4Faustin Malele Bazola5Juliana Soares Linn6ICAP at Columbia University, New York, NY, USAICAP at Columbia University in DR Congo, Kinshasa, DR CongoICAP at Columbia University in DR Congo, Kinshasa, DR CongoICAP at Columbia University, New York, NY, USAICAP at Columbia University, New York, NY, USAICAP at Columbia University in DR Congo, Kinshasa, DR CongoICAP at Columbia University, New York, NY, USABackground: In DR Congo, adolescent girls are disproportionately vulnerable to HIV. Nonetheless, females are often more engaged in the health-care system, including during antenatal care, when women enrolled on Option B+ for prevention of mother-to-child transmission of HIV initiate antiretroviral therapy (ART). We aimed to understand the extent of delayed ART initiation among adolescents and young adults newly enrolled in HIV care, and to assess whether there were any sex differences. Methods: Aggregate data from 365 ICAP-supported sites in Kinshasa and Haut-Katanga provinces in DR Congo from April 2016 to May 2017 were reviewed to describe delayed ART uptake among adolescents and young adults aged 15–24 years. Delayed uptake was defined as not beginning treatment within 1 month of enrolling in care among those eligible for ART. Pregnant and non-pregnant women were combined since available data did not disaggregate by pregnancy status. DR Congo began implementing “test and start” during the study period. All analyses used group-level data and were conducted using multivariable logistic regression, adjusting for setting and age group. Findings: Between April 2016 and May 2017, 861 adolescents and young adults (128 male and 733 female) enrolled in HIV care and treatment services. 21 (16%) males and 58 (8%) females had not begun treatment within 1 month of enrolling in care, despite eligibility for ART (odds ratio [OR] 2·28, 95% CI 1·33–3·92). The male predominance remained after controlling for setting (urban vs rural) and age group (15–19 years vs 20–24 years) (adjusted OR 2·03, 95% CI 1·17–3·53). Aggregate data did not allow for analysis of individual explanations, but reasons for delayed ART may include the need to stabilise patients before starting treatment and patients’ preferences. Interpretation: Despite being more vulnerable to HIV, female adolescents and young adults have faster ART initiation than males after enrolling in HIV treatment. It is likely that Option B+ expedites ART initiation for females. Going forwards, ICAP will strengthen its adolescent package of support with community-based adolescent-friendly interventions targeting males, with the goal to enrol all adolescents and young adults on ART in accordance with DRC's test and start guidelines. Funding: CDC/PEPFAR.http://www.sciencedirect.com/science/article/pii/S2214109X18301608
spellingShingle Sarina Dane
Tania Tchissambou
Désiré Dibulundu
Caitlin Madevu-Matson
Bibola Ngalamulume-Roberts
Faustin Malele Bazola
Juliana Soares Linn
Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
The Lancet Global Health
title Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
title_full Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
title_fullStr Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
title_full_unstemmed Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
title_short Sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with HIV in DR Congo
title_sort sex differences in delayed antiretroviral therapy initiation among adolescents and young adults living with hiv in dr congo
url http://www.sciencedirect.com/science/article/pii/S2214109X18301608
work_keys_str_mv AT sarinadane sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT taniatchissambou sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT desiredibulundu sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT caitlinmadevumatson sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT bibolangalamulumeroberts sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT faustinmalelebazola sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo
AT julianasoareslinn sexdifferencesindelayedantiretroviraltherapyinitiationamongadolescentsandyoungadultslivingwithhivindrcongo